Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Michael Stanton-Hicks, MD, clinical interests are pain, reflex sympathetic dystrophy and regional anesthesia. He is board-certified in both pain medicine and anesthesiology.
A frequent lecturer at national and international meetings, Dr. Stanton-Hicks has authored more than 130 articles, book chapters and textbooks. Dr. Stanton-Hicks is an active member and committee chairman for numerous national and international professional societies including the American Academy of Disability Evaluating Physicians, American Academy of Pain Medicine, the European Society of Regional Anesthesia and the International Association for the Study of Pain (American Pain Society). He also has been the president of many of these organizations including the American Society of Regional Anesthesia, the American Academy of Medical Infrared Imaging and the American Neuromodulation Society. In addition, Dr. Stanton-Hicks is Executive Editor of Pain Practice and serves on the editorial boards for Neuromodulation Practice and Pain Physician. He also is a reviewer for Current Review of Pain.
Dr. Stanton-Hicks has been the principal investigator for numerous funded research projects. His primary areas of research are the movement disorder of complex regional pain syndrome (also known as reflex sympathetic dystrophy), pharmacologic aspects of pain management and the use of neurostimulation in pain medicine. In 1998, Dr. Stanton-Hicks received the Distinguished Service Award from the American Society of Regional Anesthesia in recognition of his service to the society and for advancing the practice of pain medicine and regional anesthesia. In addition, Dr. Stanton-Hicks was named Scientist of the Year by the American Hershel Society, and received the William Hobbins M.D. Research Award from the American Academy of Medical Infrared Imaging for his contributions to the practice of pain medicine.
After receiving his medical degree from University of Adelaide Faculty of Medicine in Australia, Dr. Stanton-Hicks completed his internship at Queen Elizabeth Hospital in Adelaide. He completed residencies at Repatriation General Hospital in Adelaide, where he commenced training in orthopedic surgery, and the Royal Melbourne Hospital; Lasarett in Koping, Sweden; and Hammersmith Hospital in London where he completed training in anesthesia. In addition, he completed a fellowship in anesthesia at the University of Washington in Seattle.
back, back neuropathic, Back Pain, back/neck pain, CRP, complex regional pain syndrome, evaluation of back and neck pain, intensive care, interventional pain management, interventional pain management for back and neck pain, Low Back Pain, management of chronic pain, neuromodulation, neuropathic, neuropathic pain, pain, pain management, pain management including spine, Pediatric Pain, reflex sympathetic dystrophy, regional anesthesia, research, spinal cord stimulation, spine, spine pain
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/18/2014, Dr. Stanton-Hicks has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.